MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.4305
-0.0175
-3.91%
After Hours: 0.4544 +0.0239 +5.55% 18:54 02/12 EST
OPEN
0.4480
PREV CLOSE
0.4480
HIGH
0.4585
LOW
0.4291
VOLUME
414.23K
TURNOVER
--
52 WEEK HIGH
3.700
52 WEEK LOW
0.4248
MARKET CAP
17.49M
P/E (TTM)
-0.2499
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCNX last week (0202-0206)?
Weekly Report · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-Allurion, Rithm Capital, Medtronic
Reuters · 02/03 18:47
BUZZ-U.S. STOCKS ON THE MOVE-Western Digital, Broadridge, WTW
Reuters · 02/03 16:02
BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney
Reuters · 02/03 14:17
SCIENTURE HOLDINGS Reaffirms Plan To Commercially Roll Out REZENOPY In Q2
Benzinga · 02/03 13:21
Scienture Expands Access to ARBLI and Prepares for Launch of REZENOPY in 2026
Benzinga · 02/03 13:20
BUZZ-Scienture jumps after expanding access to hypertension drug
Reuters · 02/03 13:17
Scienture provides commercial update on Arbli
TipRanks · 02/03 13:11
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.